- 产品描述
- 产品组分
- 文件资源
- 营销中心
- 注意事项
- FAQ
- 文献追踪
-
Application: DB, ELISA, IF, IP, MeRIP Areas of Research: RNA Methylation Clonality: Polyclonal Conjugate: Unconjugated Host: Rabbit Isotype: IgG Purification: Affinity Purified Reactivity: Broad Range, Human, Mouse Background
N6-methyladenosine (m6A) is the most common and abundant modification in RNA molecules present in eukaryotes. The m6A modification is catalyzed by a methyltransferase complex METTL3 and removed by the recently discovered m6A RNA demethylases FTO and ALKBH5, which catalyze m6A demethylation in an ?-ketoglutarate (?-KG)- and Fe2+-dependent manner. It was shown that METTL3, FTO, and ALKBH5 play essential roles in many biological processes, ranging from development and metabolism to fertility. m6A accounts for more than 80% of all RNA base methylations and exists in various species. m6A is mainly distributed in mRNA and also occurs in non-coding RNA such as tRNA, rRNA, and snRNA. The relative abundance of m6A in mRNA transcripts has been shown to affect RNA metabolism processes such as splicing, nuclear export, translation ability and stability, and RNA transcription. Abnormal m6A methylation levels induced by defects in m6A RNA methylase and demethylase could lead to dysfunction of RNA and diseases. For example, abnormally low levels of m6A in target mRNAs due to increased FTO activity in patients with FTO mutations, through an as-yet-undefined pathway, contributes to the onset of obesity and related diseases. The dynamic and reversible chemical m6A modification in RNA may also serve as a novel epigenetic marker of profound biological significance. Therefore, more useful information for a better understanding of m6A RNA methylation levels and distribution on RNA transcripts could benefit diagnostics and therapeutics of disease.Description
N6-methyladenosine (m6A) Polyclonal Antibody. Unconjugated. Raised in: Rabbit.Formulation
Buffer: PBS with 0.02% sodium azide, 50% glycerol, pH7.3.Specificity
Human, RatIsotype
IgGPurification
Affinity PurificationImmunogen
Chemical compounds corresponding to N6-methyladenosine / m6A.Storage
Shipped at 4°C. Upon delivery aliquot and store at 4°C (short-term), or store at 20°C or -80°C (long-term). Avoid repeated freeze.Alternative Names
Anti-N6-methyladenosine, N6-methyladenosine, N6(methylnitroso)adenosine, m6A, N6-methyladenosine, 6mAApplication
NucleotideArray, DB, IP, IF; Recommended dilution: DB: 1:500-1:2000, IF: 1:50-1:200, IP:1:50-1:200关键词:- m6A兔源多克隆抗体
-
产品组分
内容
型号
规格 储存温度
m6A兔源多克隆抗体 A-1801-020 20ul -20°C m6A兔源多克隆抗体 A-1801-100 100ul -20°C 操作手册
1 1 常温
-
操作手册
文件下载 文件内容 资源说明 
A-1801-m6A兔源多克隆抗体 操作手册 
A-1801-m6A兔源多克隆抗体相关说明 宣传单页 -
注意事项
保存建议 推荐蓝冰或冰袋运输。当您收到产品后,按照说明书建议保存各组分。 -
FAQ
Q:能否替代merck的ABE572呢?
A:由于默克抗体ABE572和A-1801之间的克隆性,宿主物种,免疫原和经过验证的应用最为相似,因此A-1801可能会被用作替代品。
-
Fan HN et. al. (February 2022). METTL14-mediated m<sup>6</sup>A modification of circORC5 suppresses gastric cancer progression by regulating miR-30c-2-3p/AKT1S1 axis. Mol Cancer. 21(1):51.
Yang J et. al. (November 2021). m<sup>6</sup>A-mediated upregulation of AC008 promotes osteoarthritis progression through the miR-328-3p‒AQP1/ANKH axis. Exp Mol Med.
Lee et. al. (September 2021). YTHDF2 Suppresses Notch Signaling through Post-transcriptional Regulation on Notch1 Int J Biol Sci. 17(14):3776-3785.
Behera J et. al. (February 2021). Allyl sulfide promotes osteoblast differentiation and bone density via reducing mitochondrial DNA release mediated Kdm6b/H3K27me3 epigenetic mechanism. Biochem Biophys Res Commun. 543:87-94.
Gu Y et. al. (October 2020). Upregulation of METTL3 expression and m6A RNA methylation in placental trophoblasts in preeclampsia. Placenta. 103:43-49.
猜你喜欢
在线留言
如果您对我们的产品感兴趣,请留下您的信息,我们将尽快与您联系,谢谢!
艾维缔官网
艾德官网
B站IVDSHOW
抖音军哥聊表观
视频号艾维缔
小红书艾维缔
快手表观盒子
表观遗传学
联系我们
